0
Skip to Content
Maxwell Biosciences
HealthSpan
Pipeline
Technology
News
Team
Careers
Investors
Maxwell Biosciences
HealthSpan
Pipeline
Technology
News
Team
Careers
Investors
HealthSpan
Pipeline
Technology
News
Team
Careers
Investors
Joshua McClure 5/18/20 Joshua McClure 5/18/20

Maxwell Peptoids Active Against Herpes Simplex 1 (HSV-1)

Read More
Joshua McClure 6/11/19 Joshua McClure 6/11/19

Next Generation Virucides – Peptoids

Read More

Maxwell Biosciences, Inc.

Austin, Texas
United States of America

Company

HealthSpan
Pipeline
Technology
Team
Science
News
Careers
Investors

News

Featured
Maxwell Biosciences Secures Anti-Diarrheal US Military Agreement
Combating Infectious Diseases: Maxwell Biosciences Partners with U.S. Military 
Longevity.IO Interview with Maxwell CEO Joshua 'Scotch' McClure: How Claromers™ Could Revolutionize Longevity and Fight Infectious Disease
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer™ Technology
Maxwell Biosciences Secures US Military Research Agreement to Combat Dengue Fever

Science

Featured
Maxwell Peptoids Active Against Herpes Simplex 1 (HSV-1)
Next Generation Virucides – Peptoids

Copyright © 2016 - 2024. Maxwell Biosciences and CLAROMER are registered trademarks of Maxwell Biosciences, Inc. All rights reserved.

Unless otherwise stated, the information on this website has not been evaluated by the Food & Drug Administration. As a research organization, we do not diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition.